We are live on ! Find out more
TRAW icon

Traws Pharma
TRAW

22 hedge funds and large institutions have $102M invested in Traws Pharma in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
+22
Holders Change %
–
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$24.3M
2
WC
Weatherbie Capital
Massachusetts
+$11.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.58M
4
EA
Emerald Advisers
Pennsylvania
+$7.15M
5
Wells Fargo
Wells Fargo
California
+$5.72M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MWNA
26
Marshall Wace North America
New York
$450K – – –
TAM
27
Tocqueville Asset Management
New York
$442K – – –
SB
28
Suntrust Banks
Georgia
$430K – – –
BIM
29
BlackRock Investment Management
Delaware
$427K – – –
Bank of New York Mellon
30
Bank of New York Mellon
New York
$402K – – –
TCIM
31
TIAA CREF Investment Management
New York
$379K – – –
Charles Schwab
32
Charles Schwab
California
$333K – – –
NFA
33
Nationwide Fund Advisors
Ohio
$263K – – –
TRCT
34
Tower Research Capital (TRC)
New York
$263K – – –
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$228K – – –
TA
36
Teachers Advisors
New York
$146K – – –
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$132K – – –
Citigroup
38
Citigroup
New York
$130K – – –
NTCOC
39
Northern Trust Company of Connecticut
Connecticut
$78K – – –
SO
40
STRS Ohio
Ohio
$71K – – –
BA
41
BlackRock Advisors
Delaware
$70K – – –
KPCM
42
Kings Point Capital Management
New York
$53K – – –
BG
43
BlackRock Group
United Kingdom
$11K – – –
Barclays
44
Barclays
United Kingdom
$9K – – –
BlackRock
45
BlackRock
New York
$4K – – –
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$4K – – –
U
47
UBS
Switzerland
$3K – – –
AllianceBernstein
48
AllianceBernstein
Tennessee
$1K – – –
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4 – – –
1
2

TRAW Hedge Fund Activity: Q3 2013 in Review

22 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q3 2013, worth a combined $102M.

Buyers outnumbered sellers: 22 funds opened new TRAW positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $24.3M.

  • 22 institutional investors held Traws Pharma (TRAW) as of Q3 2013, up from 0 in Q2 2013.
  • Funds reported $102M of Traws Pharma stock for Q3 2013.
  • 22 funds opened new Traws Pharma positions in Q3 2013 and 0 closed out, a net change of +22 holders.
  • The largest Traws Pharma buyer in Q3 2013 was Deerfield Management, an estimated $24.3M added.

Based on aggregated 13F filings for Q3 2013.